According to the data from phase 3 clinical trials of the drug in 250 patients across 10 sites, the "drug works best in ...

By Dr. Gyan Pathak Claimed to be an innovative eye drop named PresVu capable of curing vision defect within 15 minutes ...

The Drug Controller General of India has suspended the manufacturing licence of PresVu eye drops Read on to know why it was suspended ...

The Central Drugs Standard Control Organisation (CDSCO) said that it was suspending its approval for the pilocarpine ...

India's drug regulator has suspended the permission granted to manufacture and sell their new eye drops, PresVu, which ...

Regulatory approval to Entod Pharma for PresVu, meant to treat presbyopia, was revoked as the firm marketed it as a ...

Entod Pharma to challenge DCGI's suspension of permission for PresVu in court: Our Bureau, New Delhi Thursday, September 12, 2024, 13:45 Hrs [IST] Entod Pharmaceuticals announced ...

This would enable someone with presbyopia to see better. Pilocarpine, itself, is not a new application in ophthalmology, or even, presbyopia. It has been used to treat glaucoma, though its use waned ...

Entod Pharmaceuticals denies making false claims about their new PresVu eye drops and plans to challenge the suspension by ...

The approval given to Entod was only for treating presbyopia in adults, the drug regulator's order said, adding that it was ...

On September 4, the drug regulator had asked for an explanation from the company for the claims it made in the press following which the drug-maker also submitted its response.

The Drugs Controller General of India (DCGI) stated in an order dated September 10 that the Directorate had approved on August 20 for the production and distribution of Pilocarpine Hydrochloride ...